
|Poll|October 17, 2022
Poll results: Will you use biosimilars in your ophthalmic practice?
Author(s)Sheryl Stevenson, OT Staff Reports
Results from our recent poll indicate that many ophthalmologists (63%) plan to use biosimilars in their clinical practice.
Advertisement
Ophthalmology Times® polled our audience with the following question from September 26, 2022 to October 10, 2022: Will you use biosimilars in your ophthalmic practice?
The poll appeared on
37 responses were recorded, in total. Of these:
23% responded, "Yes, I plan to use biosimilars in my practice."
14% responded, "No, I do not plan to use biosimilars in my practice."
.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
Opuviz aflibercept biosimilar launches in Europe for retinal diseases
4
Study links alcohol consumption to earlier advanced presbyopia in men
5





















